Sports News

Mutual of America Capital Management LLC Sells 4,317 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)


Mutual of America Capital Management LLC cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 96,179 shares of the pharmacy operator’s stock after selling 4,317 shares during the period. Mutual of America Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $2,511,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Walgreens Boots Alliance by 4.6% in the first quarter. BlackRock Inc. now owns 63,406,129 shares of the pharmacy operator’s stock worth $2,192,584,000 after purchasing an additional 2,797,885 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after purchasing an additional 3,013,807 shares during the last quarter. Morgan Stanley increased its holdings in shares of Walgreens Boots Alliance by 15.8% in the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after purchasing an additional 1,720,228 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 84,503.5% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock worth $311,053,000 after purchasing an additional 8,315,989 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Trading Up 3.7 %

Shares of NASDAQ WBA opened at $18.24 on Friday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $20.42 and a 200 day moving average price of $21.93. Walgreens Boots Alliance, Inc. has a 52-week low of $17.51 and a 52-week high of $36.14.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.16 earnings per share. As a group, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on WBA shares. HSBC reissued a “reduce” rating and set a $20.00 price objective (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Truist Financial reissued a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Morgan Stanley reduced their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. UBS Group reduced their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Finally, Barclays started coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective on the stock. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $24.36.

Read Our Latest Analysis on WBA

Insider Activity at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Inderpal S. Bhandari bought 3,000 shares of the stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at $54,150. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company’s stock, valued at $99,992.64. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 13,456 shares of company stock worth $270,423. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)



Receive News & Ratings for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Articles

Leave a Reply

Back to top button